Pelareorep for treating metastatic malignant melanoma after previous therapy [ID941]
Discontinued
Reference number: GID-TA10686
Following on from information provided to NICE by the company in May 2020 the appraisal of Pelareorep for treating metastatic malignant melanoma after previous therapy [ID941] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.